{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:48:08Z","timestamp":1760150888137,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and\/or contact with the general practitioner and\/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. Results: A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. Conclusions: Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities.<\/jats:p>","DOI":"10.3390\/medicina58020219","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T22:16:18Z","timestamp":1643753778000},"page":"219","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Hospitalization in an Endocrinology Department on Vaccination Coverage in People Living with Diabetes: A Real-Life Study"],"prefix":"10.3390","volume":"58","author":[{"given":"Laura","family":"Lohan","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, 34295 Montpellier, France"},{"name":"Phymedexp, University of Montpellier, INSERM, CNRS, CHRU de Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charl\u00e8ne","family":"Cool","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Toulouse University Hospital, 31059 Toulouse, France"},{"name":"Centre for Epidemiology and Population Health Research (CERPOP), UMR 1027, INSERM, University of Toulouse (UPS), 31059 Toulouse, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loriane","family":"Viault","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Cestac","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Toulouse University Hospital, 31059 Toulouse, France"},{"name":"Centre for Epidemiology and Population Health Research (CERPOP), UMR 1027, INSERM, University of Toulouse (UPS), 31059 Toulouse, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3407-7263","authenticated-orcid":false,"given":"Eric","family":"Renard","sequence":"additional","affiliation":[{"name":"Endocrinology-Diabetology-Nutrition Department, University of Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0720-6277","authenticated-orcid":false,"given":"Florence","family":"Galtier","sequence":"additional","affiliation":[{"name":"Endocrinology-Diabetology-Nutrition Department, University of Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Villiet","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Avignon","sequence":"additional","affiliation":[{"name":"Endocrinology-Diabetology-Nutrition Department, University of Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Sultan","sequence":"additional","affiliation":[{"name":"Phymedexp, University of Montpellier, INSERM, CNRS, CHRU de Montpellier, 34295 Montpellier, France"},{"name":"Endocrinology-Diabetology-Nutrition Department, University of Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-2686","authenticated-orcid":false,"given":"Cyril","family":"Breuker","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, 34295 Montpellier, France"},{"name":"Phymedexp, University of Montpellier, INSERM, CNRS, CHRU de Montpellier, 34295 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/dc17-2131","article-title":"Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study","volume":"41","author":"Carey","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2337\/dc14-2820","article-title":"Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 Diabetes","volume":"38","author":"Magliano","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2019). 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019. Diabetes Care, 42, S34\u2013S45.","DOI":"10.2337\/dc19-S004"},{"key":"ref_5","unstructured":"Centers for Disease Control and Prevention (2011). Tetanus surveillance\u2014United States, 2001\u20132008. MMWR Morb. Mortal. Wkly. Rep., 60, 365\u2013369."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"636.e1","DOI":"10.1016\/j.amjmed.2015.10.031","article-title":"Uptake of Influenza Vaccination and Missed Opportunities Among Adults with High-Risk Conditions, United States, 2013","volume":"129","author":"Lu","year":"2016","journal-title":"Am. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1080\/21645515.2020.1849518","article-title":"Risk factors for invasive meningococcal disease: A retrospective analysis of the French national public health insurance database","volume":"17","author":"Taha","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S095026889700825X","article-title":"Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes","volume":"119","author":"Colquhoun","year":"1997","journal-title":"Epidemiol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2337\/dc05-2517","article-title":"Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients","volume":"29","author":"Verheij","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30580","DOI":"10.2807\/1560-7917.ES.2017.22.30.30580","article-title":"2015\/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project","volume":"22","author":"Rondy","year":"2017","journal-title":"Eurosurveillance"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1016\/j.vaccine.2018.10.093","article-title":"Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012\u20132016","volume":"36","author":"Shang","year":"2018","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/diacare.20.7.1212","article-title":"Reported rates, incentives, and effectiveness of major vaccinations in 501 attendees at two diabetes clinics","volume":"20","author":"Selvais","year":"1997","journal-title":"Diabetes Care"},{"key":"ref_13","unstructured":"French Ministry of Solidarity and Health (2021, October 15). Vaccination Schedule and Recommendations, Available online: https:\/\/solidarites-sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal."},{"key":"ref_14","first-page":"12","article-title":"R\u00e9f\u00e9rentiel de la Soci\u00e9t\u00e9 francophone du diab\u00e8te (SFD): Vaccination chez la personne diab\u00e9tique","volume":"14","author":"Sultan","year":"2020","journal-title":"M\u00e9d. Mal. M\u00e9tab."},{"key":"ref_15","unstructured":"American Diabetes Association (2021, March 26). Vaccination Practices for Adults with Diabetes. Available online: https:\/\/www.diabeteseducator.org\/docs\/default-source\/practice\/educator-tools\/vaccination-practices-for-adults-with-diabetesv2.pdf?sfvrsn=2."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1080\/21645515.2021.1971473","article-title":"Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations","volume":"17","author":"Andreoni","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_17","unstructured":"Centers for Disease Control and Prevention (2021, October 15). Diabetes Type 1 and Type 2 and Adult Vaccination, Available online: https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/health-conditions\/diabetes.html."},{"key":"ref_18","unstructured":"Ministero della Salute (2021, October 15). Persone a Rischio Per Patologia, Available online: https:\/\/www.salute.gov.it\/portale\/vaccinazioni\/dettaglioContenutiVaccinazioni.jsp?lingua=italiano&id=4811&area=vaccinazioni&menu=fasce."},{"key":"ref_19","unstructured":"Diabetes Austria (2021, October 15). Living with Diabetes, Preventing Complications. Available online: https:\/\/www.diabetesaustralia.com.au\/living-with-diabetes\/preventing-complications\/influenza\/."},{"key":"ref_20","unstructured":"Diabetes Canada (2021, October 15). Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations. Available online: https:\/\/guidelines.diabetes.ca\/cpg\/chapter19."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4161\/hv.23926","article-title":"Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain","volume":"9","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ebiom.2015.06.018","article-title":"Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France","volume":"2","author":"Verger","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"930.e1","DOI":"10.1016\/j.cmi.2015.06.017","article-title":"Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: A follow-up study from 2008 to 2011 in southeastern France","volume":"21","author":"Verger","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1080\/21645515.2019.1587274","article-title":"Seasonal influenza self-vaccination behaviours and attitudes among nurses in Southeastern France","volume":"15","author":"Wilson","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2016.08.085","article-title":"Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis","volume":"34","author":"Isenor","year":"2016","journal-title":"Vaccine"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Isenor, J.E., O\u2019Reilly, B.A., and Bowles, S.K. (2018). Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016. BMC Public Health, 18.","DOI":"10.1186\/s12889-018-5697-x"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Czech, M., Balcerzak, M., Antczak, A., Byliniak, M., Piotrowska-Rutkowska, E., Drozd, M., Juszczyk, G., Religioni, U., Vaillancourt, R., and Merks, P. (2020). Flu Vaccinations in Pharmacies-A Review of Pharmacists Fighting Pandemics and Infectious Diseases. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17217945"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.sapharm.2020.08.021","article-title":"Letter: Impact of the COVID-19 pandemic on pharmacist-administered vaccination services","volume":"17","author":"Patel","year":"2021","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1097\/PTS.0000000000000420","article-title":"Medication Errors at Hospital Admission and Discharge: Risk Factors and Impact of Medication Reconciliation Process to Improve Healthcare","volume":"17","author":"Breuker","year":"2021","journal-title":"J. Patient Saf."},{"key":"ref_30","unstructured":"(2013). Model-Building Strategies and Methods for Logistic Regression. Applied Logistic Regression, Wiley. [3rd ed.]."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"A comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Blanchi, S., Vaux, J., Toque, J.M., Hery, L., Laforest, S., Piccoli, G.B., and Crochette, N. (2020). Impact of a Catch-Up Strategy of DT-IPV Vaccination during Hospitalization on Vaccination Coverage among People Over 65 Years of Age in France: The HOSPIVAC Study (Vaccination during Hospitalization). Vaccines, 8.","DOI":"10.3390\/vaccines8020292"},{"key":"ref_33","first-page":"6","article-title":"Le rapport \u00e0 la vaccination des personnes diab\u00e9tiques. R\u00e9sultats pr\u00e9liminaires d\u2019une \u00e9tude aupr\u00e8s de 3731 personnes diab\u00e9tiques","volume":"14","author":"Guillot","year":"2020","journal-title":"M\u00e9d. Mal. M\u00e9tab."},{"key":"ref_34","unstructured":"Wellcome (2021, March 26). Wellcome Global Monitor 2018 Rapports. Available online: https:\/\/wellcome.ac.uk\/reports\/wellcome-global-monitor\/2018."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ebiom.2016.08.042","article-title":"The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey","volume":"12","author":"Larson","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_36","unstructured":"Le Monde with AFP (2021, March 26). WHO Justifies Its Management of Influenza A. Available online: https:\/\/www.lemonde.fr\/epidemie-grippe-a\/article\/2010\/01\/26\/l-oms-justifie-sa-gestion-de-la-grippe-a_1296718_1225408.html."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1016\/j.vaccine.2016.10.042","article-title":"Vaccine hesitancy and healthcare providers","volume":"34","author":"Paterson","year":"2016","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Breuker, C., Guedj, A.M., Allan, M., Coinus, L., Molinari, N., Chapet, N., Roubille, F., Le Quintrec, M., Duhalde, V., and Jouglen, J. (2021). The COVID-19 Pandemic Led to a Small Increase in Changed Mentality Regarding Infection Risk without Any Change in Willingness to Be Vaccinated in Chronic Diseases Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10173967"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: The CORONADO study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2016.12.003","article-title":"Patients with diabetes are at high risk of serious medication errors at hospital: Interest of clinical pharmacist intervention to improve healthcare","volume":"38","author":"Breuker","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1034","DOI":"10.1097\/PTS.0000000000000764","article-title":"Hypoglycemia While Driving in Insulin-Treated Patients: Incidence and Risk Factors","volume":"17","author":"Lohan","year":"2021","journal-title":"J. Patient Saf."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lohan, L., Galtier, F., Manson, T., Mura, T., Castet-Nicolas, A., Faure, D., Chapet, N., Leclercq, F., Pasquie, J.L., and Roubille, F. (2021). Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology Units. Medicina, 57.","DOI":"10.3390\/medicina57121376"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2018.04.068","article-title":"Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors","volume":"268","author":"Breuker","year":"2018","journal-title":"Int. J. Cardiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/2\/219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:12:39Z","timestamp":1760134359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/2\/219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["medicina58020219"],"URL":"https:\/\/doi.org\/10.3390\/medicina58020219","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}